Close Menu

Memorial Sloan-Kettering

The five new grants, part of the Genomics of Gene Regulation program, will fund research into the mechanisms controlling gene expression.

By profiling samples from nearly three-dozen individuals with acute myeloid leukemia that developed from chronic myeloproliferative neoplasms, researchers have identified new mutation combinations that can spur this leukemic transformation.

Genetic testing laboratory Pathway Genomics today announced a partnership with the Prospective Registry of Multiplex Testing, an online registry for patients who have undergone testing for cancer-causing genetic mutations. Pathway Genomics will provide information about the registry to patients and healthcare providers receiving panel tests.

NEW YORK (GenomeWeb) -- Quest Diagnostics has launched a next-generation sequencing-based 34-gene panel called OncoVantage and plans to collaborate with Memorial Sloan-Kettering Cancer Center for clinical annotation of the test, Quest said this week.

SAN DIEGO (GenomeWeb News) — Reporting incidental or secondary findings may pose a challenge for the cancer field, a panel at this year's American Association for Cancer Research meeting said.

NEW YORK (GenomeWeb News) – A trio of papers in Nature Genetics describe findings from genomic studies of an ovarian cancer called small cell carcinoma of the ovary, hypercalcemic type, that implicate mutations in the SMARCA4 gene in the development of the disease.

NEW YORK (GenomeWeb News) – A pair of studies that appeared in Nature Genetics yesterday implicated mutations in the ESR1 gene in the development of hormone-resistant metastatic breast cancer.

NEW YORK (GenomeWeb News) – A flurry of new studies is outlining findings from the first phase of an analysis that brings together Cancer Genome Atlas data on up to a dozen cancer types.

NEW YORK (GenomeWeb News) – The Damon Runyon Cancer Research Foundation has awarded $3.6 million to nine young investigators who are pursuing a range of efforts to better understand, and eventually treat, cancer at the molecular level.

NEW YORK (GenomeWeb News) – A Memorial Sloan-Kettering Cancer Center-led team has taken an exome- and genome-sequencing centered look at the mutations that may be found in the salivary gland cancer adenoid cystic carcinoma, or ACC.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.